AU5184293A - Phthalazinone derivatives - Google Patents

Phthalazinone derivatives

Info

Publication number: AU5184293A
Authority: AU; Australia
Prior art keywords: phthalazinone derivatives; phthalazinone; derivatives
Prior art date: 1992-11-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU51842/93A

Inventor

Not Given Name

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Ciba Geigy AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-11-27

Filing date

1993-11-22

Publication date

1994-06-09

1993-11-22 Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG

1994-06-09 Publication of AU5184293A publication Critical patent/AU5184293A/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AU51842/93A 1992-11-27 1993-11-22 Phthalazinone derivatives Abandoned AU5184293A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH365092		1992-11-27
CH3650/92		1992-11-27

Publications (1)

Publication Number	Publication Date
AU5184293A true AU5184293A (en)	1994-06-09

Family

ID=4260564

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU51842/93A Abandoned AU5184293A (en)	1992-11-27	1993-11-22	Phthalazinone derivatives

Country Status (8)

Country	Link
EP (1)	EP0600831A1 (en)
JP (1)	JPH06228108A (en)
KR (1)	KR940011448A (en)
CN (1)	CN1095714A (en)
AU (1)	AU5184293A (en)
CA (1)	CA2109992A1 (en)
IL (1)	IL107749A0 (en)
ZA (1)	ZA938847B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6258812B1 (en)	1997-02-13	2001-07-10	Novartis Ag	Phthalazines with angiogenesis inhibiting activity

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0111078D0 (en)	2001-05-04	2001-06-27	Novartis Ag	Organic compounds
US20030073692A1 (en)	2001-08-07	2003-04-17	Pharmacia & Upjohn S.P.A.	Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
GB0305681D0 (en)	2003-03-12	2003-04-16	Kudos Pharm Ltd	Phthalazinone derivatives
GB0317466D0 (en)	2003-07-25	2003-08-27	Univ Sheffield	Use
PL2251327T3 (en) *	2003-11-19	2014-07-31	Array Biopharma Inc	Heterocyclic inhibitors of mek
HUE025996T2 (en)	2003-12-01	2016-05-30	Kudos Pharm Ltd	DNA damage repair inhibitors for treatment of cancer
US7759337B2 (en) *	2005-03-03	2010-07-20	Amgen Inc.	Phthalazine compounds and methods of use
AU2007285057B2 (en)	2006-08-15	2013-08-01	Agency For Science, Technology And Research	Mesenchymal stem cell conditioned medium
KR101640381B1 (en)	2008-02-22	2016-07-18	에이전시 포 사이언스, 테크놀로지 앤드 리서치	Mesenchymal stem cell particles
EP2479260B1 (en)	2008-03-17	2016-01-06	Agency For Science, Technology And Research	Microcarriers for stem cell culture
JP5892939B2 (en)	2009-11-02	2016-03-23	エージェンシーフォーサイエンス，テクノロジーアンドリサーチ	Method for monitoring cell status and method for immortalizing mesenchymal stem cells
SG183579A1 (en)	2011-02-11	2012-09-27	Agency Science Tech & Res	Methods of detecting therapeutic exosomes
WO2015140005A1 (en)	2014-03-19	2015-09-24	Ifom Fondazione Istituto Firc Di Oncologia Molecolare	Method of generation of pluripotent cells
EP3525806B1 (en)	2016-10-12	2023-02-15	Agency For Science, Technology And Research	Method for lyophilising an exosome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU653024B2 (en) *	1991-05-30	1994-09-15	Novartis Ag	Substituted diaminophthalimides and analogues

1993
- 1993-11-18 EP EP93810801A patent/EP0600831A1/en not_active Withdrawn
- 1993-11-22 AU AU51842/93A patent/AU5184293A/en not_active Abandoned
- 1993-11-25 IL IL10774993A patent/IL107749A0/en unknown
- 1993-11-25 CA CA002109992A patent/CA2109992A1/en not_active Abandoned
- 1993-11-26 ZA ZA938847A patent/ZA938847B/en unknown
- 1993-11-26 JP JP5296611A patent/JPH06228108A/en active Pending
- 1993-11-26 CN CN93114934A patent/CN1095714A/en active Pending
- 1993-11-27 KR KR1019930025482A patent/KR940011448A/en not_active Application Discontinuation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6258812B1 (en)	1997-02-13	2001-07-10	Novartis Ag	Phthalazines with angiogenesis inhibiting activity
US6514974B2 (en)	1997-02-13	2003-02-04	Novartis Ag	Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity

Also Published As

Publication number	Publication date
JPH06228108A (en)	1994-08-16
CA2109992A1 (en)	1994-05-28
IL107749A0 (en)	1994-02-27
KR940011448A (en)	1994-06-21
ZA938847B (en)	1994-05-27
CN1095714A (en)	1994-11-30
EP0600831A1 (en)	1994-06-08

Publication	Publication Date	Title
AU4156293A (en)	1994-01-06	Thiazolylvinylphenyl derivatives
AU3692393A (en)	1993-10-21	Indole derivatives
AU7159994A (en)	1995-03-30	3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
AU3349893A (en)	1993-08-03	Indole derivatives
AU1655192A (en)	1992-12-21	Antivizal dibenzothiazepinone derivatives
AU3561193A (en)	1993-10-07	TNF-muteins
AU3991693A (en)	1993-12-09	Pyrazinoindoles
AU4123793A (en)	1993-12-23	Benzimidazole derivatives
AU3551493A (en)	1993-09-30	Steroid derivatives
AU3388893A (en)	1993-09-23	Pyrimidine derivatives
AU3042892A (en)	1994-07-14	Rockbolt
AU5184293A (en)	1994-06-09	Phthalazinone derivatives
AU685767B2 (en)	1998-01-29	Substituted benzazepinones
AU3406793A (en)	1993-09-23	2-oxoquinoline derivatives
AU4829793A (en)	1994-04-26	Quinazoline derivatives
AU4949293A (en)	1994-03-29	Indazole derivatives
AU4504593A (en)	1994-01-31	Fungicidal 2-imidazoline-5-one and 2-imidazoline-5-thione derivatives
AU1033992A (en)	1992-08-06	3-quinuclidine derivatives
AU3195993A (en)	1993-07-29	Heterocyclic derivatives
AU685768B2 (en)	1998-01-29	Benzazepinone derivatives
AU3461693A (en)	1993-09-03	Saddle-cloth
AU3562193A (en)	1993-10-07	Morpholin- and thiomorpholin-4-ylamides
AU3697893A (en)	1993-10-21	Propenoyl-imidazole derivatives
AU3687393A (en)	1993-10-14	Piperazine derivatives
AU2686592A (en)	1993-05-03	Tetraphenylporphyn derivatives